Prevalence of pyruvate kinase deficiency among the south Iranian population: quantitative assay and molecular

M Yavarian1, M Karimi, M Shahriary

  • 1Hematology Research Center, School of Medicine, Shiraz University of Medical Science, Shiraz, Iran. yavarian@sums.ac.ir

Insights

Pyruvate kinase (PK) deficiency was screened in 146 patients, revealing significantly lower enzyme activity compared to healthy adults. Fourteen distinct mutations in the R-PK gene were identified in 74 individuals, with G1168A and G1529A being the most prevalent.

Area of Science:

  • Genetics
  • Hematology
  • Biochemistry

Background:

  • Pyruvate kinase (PK) deficiency is a genetic disorder affecting red blood cells.
  • Hematological index analysis is a key method for pre-selecting patients for screening.

Purpose of the Study:

  • To screen a pre-selected cohort for pyruvate kinase deficiency.
  • To identify and characterize mutations in the R-PK gene associated with low enzyme activity.

Main Methods:

  • Screening of 146 patients pre-selected from 4017 individuals based on hematological indices.
  • Measurement of pyruvate kinase activity in erythrocytes.
  • Identification of mutations in the coding sequence of the R-PK gene.

Main Results:

  • Average PK activity in the patient cohort was 1.9% IU/g Hb, significantly lower than the 3.9-9.8 IU/g Hb range in healthy adults.
  • Fourteen different mutations were identified in the R-PK gene in 74 individuals.
  • G1168A and G1529A mutations in exon 11 were the most common, found in 54% of cases.

Conclusions:

  • The study successfully identified numerous R-PK gene mutations in patients with low pyruvate kinase activity.
  • Common mutations like G1168A and G1529A are significant contributors to PK deficiency.
  • Linkage disequilibrium suggests a multi-centric origin for these mutations, warranting further investigation into regulatory regions.

Related Concept Videos